Dabur Pharma receives USFDA approval for marketing Novantrone

Subscribe to Oneindia News

New Delhi, May 21 (UNI) Dabur Pharma Ltd today said it has received the final approval to market its generic version of EMD Serono's Novantrone (Mitoxantrone Hydrochloride) Injection 20 mg, 25 mg and 30 mg.

The firm's Abbreviated New Drug Application (ANDA) has received US Food and Drug Administration (USFDA) final approval to market the generic version of EMD Serono's Novantrone injection 20 mg, 25 mg and 30 mg, a company statement said.

It is used for the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis.

UNI SR AK AS1303

Please Wait while comments are loading...